Zonisamide-induced weight loss in schizophrenia: case series

Clinical Neuropharmacology
Jaewon YangSeung-Hyun Kim

Abstract

Weight gain and metabolic disturbances constitute bothersome problems in schizophrenic patients treated with atypical antipsychotics. Several medications, exercise regimens, and lifestyle changes have been used in attempts to ameliorate these problems. We describe 3 patients with schizophrenia who manifested distinct weight loss and reduction in waist circumference during medication with zonisamide. This report suggests that zonisamide might be associated with weight loss in patients with schizophrenia.

References

Nov 1, 1995·Obesity Research·P TerryS J Cooper
Nov 1, 1995·Epilepsy Research·M OkadaY Fukushima
Apr 21, 1999·Epilepsy Research·M OkadaS Kaneko
Nov 28, 2001·Neurology·E FaughtUNKNOWN Zonisamide 922 Trial Group
Apr 10, 2003·JAMA : the Journal of the American Medical Association·Kishore M GaddeK Ranga R Krishnan
Jan 28, 2004·The Journal of Clinical Psychiatry·Susan L McElroyPaul E Keck
Mar 9, 2004·The Journal of Clinical Psychiatry·UNKNOWN American Diabetes AssociationUNKNOWN North American Association for the Study of Obesity
Feb 12, 2005·The Journal of Clinical Psychiatry·Amit AnandJeffrey Lightfoot
May 14, 2005·The Journal of Clinical Psychiatry·Susan L McElroyRobert M Post
Jun 28, 2005·Drugs·Lisa L Ioannides-DemosJohn J McNeil
Mar 18, 2006·Epilepsy & Behavior : E&B·William A Tosches, Jonathan Tisdell
Dec 30, 2006·The Journal of Clinical Psychiatry·Susan L McElroyJames I Hudson
Jul 14, 2007·Journal of Psychiatric Research·Po W WangTerence A Ketter
Mar 7, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Nicholas M WallingfordMichael A Cowley

❮ Previous
Next ❯

Citations

Apr 11, 2014·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Mathew L NguyenMichael A Shapiro
Dec 19, 2015·International Journal of Psychiatry in Medicine·Michael ShapiroMathew Nguyen
Sep 26, 2015·Hospital Pharmacy·Joyce A Generali, Dennis J Cada
Dec 7, 2013·Expert Review of Clinical Pharmacology·Joseph ChukwuGianpiero L Cavalleri
Aug 7, 2010·Pharmacology, Biochemistry, and Behavior·G A Kennett, P G Clifton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

© 2022 Meta ULC. All rights reserved